Recalls & Warnings December 08, 2017 Limbrel Capsules for Osteoarthritis Linked With Potentially Life-Threatening Health Risk, FDA Warns On December 4, 2017, the FDA urged consumers not to take Limbrel (Primus Pharmaceuticals), a capsule marketed to manage the metabolic processes associated with osteoarthritis, because it has been associated with serious adverse events, including drug-induced liver injury and a lung
However, the progressive effect of exogenous GSH in controlling growth, development and yield under abiotic stress has been reported in Arabidopsis mung bean and soybean 11,29,30
Sequence of a putative glucose 6-phosphate translocase, mutated in glycogen storage disease type Ib
Reduction of brain phosphocratine in bipolar II disorder detected by phosphorus-31 magnetic resonance spectroscopy